Pfizer
- Advice
- Hold
Pfizer Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Pfizer
Start SIPPfizer Investment Rating
-
Master Rating:
-
Pfizer (Nse) has an operating revenue of Rs. 2,401.78 Cr. on a trailing 12-month basis. An annual revenue growth of 15% is outstanding, Pre-tax margin of 30% is great, ROE of 21% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 88 which is a GOOD score indicating consistency in earnings, a RS Rating of 28 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 90 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 622 | 637 | 593 | 550 |
| Operating Expenses Qtr Cr | 418 | 406 | 401 | 384 |
| Operating Profit Qtr Cr | 203 | 232 | 192 | 165 |
| Depreciation Qtr Cr | 26 | 26 | 27 | 34 |
| Interest Qtr Cr | 4 | 3 | 4 | 4 |
| Tax Qtr Cr | 50 | 104 | 11 | 19 |
| Net Profit Qtr Cr | 151 | 311 | 33 | 126 |
Pfizer Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- 3595.65
- 50 Day
- 3781.69
- 100 Day
- 3966.21
- 200 Day
- 4153.22
- 20 Day
- 3610.37
- 50 Day
- 3786.49
- 100 Day
- 4097.53
- 200 Day
- 4166.78
Pfizer Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 3549.07 |
| Second Resistance | 3595.54 |
| Third Resistance | 3666.07 |
| RSI | 23.8 |
| MFI | 20.64 |
| MACD Single Line | -97.65 |
| MACD | -100.35 |
| Support | |
|---|---|
| First Resistance | 3432.07 |
| Second Resistance | 3361.54 |
| Third Resistance | 3315.07 |
Pfizer Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 15,267 | 1,008,233 | 66.04 |
| Week | 11,710 | 714,325 | 61 |
| 1 Month | 9,783 | 591,703 | 60.48 |
| 6 Month | 15,685 | 987,991 | 62.99 |
Pfizer Result Highlights
Pfizer Synopsis
NSE-Medical-Diversified
Pfizer Ltd. is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 2610.99 Cr. and Equity Capital is Rs. 45.75 Cr. for the Year ended 31/03/2022. Pfizer Ltd. is a Public Limited Listed company incorporated on 21/11/1950 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24231MH1950PLC008311 and registration number is 008311.| Market Cap | 15,862 |
| Sales | 2,402 |
| Shares in Float | 1.65 |
| No of funds | 120 |
| Yield | 1.01 |
| Book Value | 5.54 |
| U/D Vol ratio | 0.4 |
| LTDebt / Equity | |
| Alpha | -0.08 |
| Beta | 0.39 |
Pfizer
| Owner Name | Dec-22 | Sep-22 | Jun-22 |
|---|---|---|---|
| Promoters | 63.92% | 63.92% | 63.92% |
| Mutual Funds | 5.97% | 6.51% | 7.17% |
| Insurance Companies | 8.91% | 8.32% | 0.73% |
| Foreign Portfolio Investors | 2.77% | 2.55% | 2.55% |
| Financial Institutions/ Banks | 0.02% | 0.02% | 0.02% |
| Individual Investors | 13.72% | 13.94% | 14.09% |
| Others | 4.69% | 4.74% | 11.52% |
Pfizer Management
| Name | Designation |
|---|---|
| Mr. S Sridhar | Managing Director |
| Mr. Milind Patil | Executive Director (Finance) & CFO |
| Mr. Samir Kazi | Executive Director |
| Mr. Sunil Lalbhai | Independent Director |
| Mr. Pradip Shah | Chairman & Ind.Director |
| Mr. Uday Khanna | Independent Director |
| Ms. Meena Ganesh | Independent Director |
Pfizer Forecast
Price Estimates
Pfizer FAQs
What is Share Price of Pfizer ?
Pfizer share price is ₹3467 As on 02 April, 2023 | 04:03
What is the Market Cap of Pfizer ?
The Market Cap of Pfizer is ₹15861.4 Cr As on 02 April, 2023 | 04:03
What is the P/E ratio of Pfizer ?
The P/E ratio of Pfizer is 25.6 As on 02 April, 2023 | 04:03
What is the PB ratio of Pfizer ?
The PB ratio of Pfizer is 5.5 As on 02 April, 2023 | 04:03